Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 4/20 | 0.48 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | DRD1 | P21728 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL258731 | 0.89 | ESR1 (0.43) | ESR1ESR2CYP3A4TDP1 | |
| SCHEMBL5810167 | 0.87 | ESR1 (0.54) | ESR1ESR2CYP3A4TDP1DRD1 | |
| SCHEMBL3962146 | 0.87 | ESR1 (0.54) | ESR1ESR2CYP3A4TDP1DRD1 | |
| SCHEMBL3790921 | 0.87 | ESR1 (0.42) | ESR1ESR2CYP3A4TDP1 | |
| SCHEMBL21386422 | 0.82 | ESR1 (0.39) | ESR1ESR2 | |
| SCHEMBL14101198 | 0.78 | ESR1 (0.46) | ESR1ESR2CYP3A4TDP1DRD1 | |
| SCHEMBL18573342 | 0.78 | CYP3A4 (0.50) | ESR1ESR2CYP3A4TDP1DRD1 | |
| SCHEMBL4918290 | 0.78 | ESR1 (0.46) | ESR1ESR2CYP3A4TDP1DRD1 | |
| SCHEMBL11648324 | 0.78 | ESR1 (0.70) | ESR1ESR2CYP3A4TDP1 | |
| SCHEMBL40441 | 0.78 | ESR1 (0.70) | ESR1ESR2CYP3A4TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3543007-B1 | LAMINATE | DAIKIN IND LTD (JP) | 2023-11-22 | — | — | EP | disclosed |
| US-7754924-B2 | Process for the monosulfonation of aromatic phosphines, and zwitterionic product derived therefrom | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-07-13 | — | — | US | disclosed |
| US-20080221363-A1 | Process for the Monosulfonation of Aromatic Phosphines, and Zwitterionic Product Derived Therefrom | DOW GLOBAL TECHNOLOGIES INC. (US) | 2008-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080221363-A1 | Process for the Monosulfonation of Aromatic Phosphines, and Zwitterionic Product Derived Therefrom | ITK, WEE1, WASF2 | ESR1 4115/4885ESR2 4795/4885CYP3A4 3702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.